Comparison of chlorambucil and Myleran® in chronic lymphocytic and granulocytic leukemia
- 30 September 1959
- journal article
- Published by Elsevier in American Journal Of Medicine
- Vol. 27 (3), 424-432
- https://doi.org/10.1016/0002-9343(59)90008-7
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- DESIGN OF ALKYLATING AGENTS FOR SELECTIVITY OF ACTIONAnnals of the New York Academy of Sciences, 1958
- IN VITRO REACTIONS OF BIOLOGICAL ALKYLATING AGENTSAnnals of the New York Academy of Sciences, 1958
- HEMATOLOGICAL EFFECTS OF THE ALKYLATING AGENTSAnnals of the New York Academy of Sciences, 1958
- MYLERAN AND TRIETHYLENE MELAMINE IN THE TREATMENT OF CHRONIC GRANULOCYTIC LEUKEMIAAnnals of the New York Academy of Sciences, 1958
- Clinical Trials of p-(Di-2-chloroethylamine)-phenylbutyric Acid (CB 1348) in Malignant LymphomaBMJ, 1955
- MYLERAN IN CHRONIC MYELOID LEUKÆMIAThe Lancet, 1955
- A Comparison of the Effects of Radiation and Radiomimetic Chemicals on the BloodBritish Journal of Haematology, 1955
- MYLERAN IN CHRONIC MYELOID LEUKÆMIA RESULTS OF TREATMENTThe Lancet, 1953
- The Chemistry of Cytotoxic Alkylating AgentsAdvances in Cancer Research, 1953
- MYLERAN IN CHRONIC MYELOID LEUKÆMIA CHEMICAL CONSTITUTION AND BIOLOGICAL ACTIONThe Lancet, 1953